About

ABOUT US

african male doctor
About Us

Treatment for Overactive Bladder

URO-1 develops breakthrough products for office procedures in Urology and Urogynecology, which improve clinical outcomes, enhance patient experience and increase procedure efficiency.

These products increase the diagnostic accuracy of prostate biopsy, reduce workload and improve workflow in the clinic and the pathology lab.

Meet the team

Management Team

Ted Belleza
President & CEO
Jack Snoke
COO & CTO
John J. Smith MD, FACS
CMO
Philip Allred
VP R&D
Chloe Chan
Consulting CFO
READ ABOUT
Our Story

URO-1 creates breakthrough solutions for office procedures in urology which improve outcome, patient experience and procedure efficiency.

URO-1 is a portfolio company of the North Carolina Biotechnology Center.
www.ncbiotech.org